224 related articles for article (PubMed ID: 28116670)
21. Programmable activation of Bombyx gene expression using CRISPR/dCas9 fusion systems.
Wang XG; Ma SY; Chang JS; Shi R; Wang RL; Zhao P; Xia QY
Insect Sci; 2019 Dec; 26(6):983-990. PubMed ID: 30088341
[TBL] [Abstract][Full Text] [Related]
22. GAPTrap: A Simple Expression System for Pluripotent Stem Cells and Their Derivatives.
Kao T; Labonne T; Niclis JC; Chaurasia R; Lokmic Z; Qian E; Bruveris FF; Howden SE; Motazedian A; Schiesser JV; Costa M; Sourris K; Ng E; Anderson D; Giudice A; Farlie P; Cheung M; Lamande SR; Penington AJ; Parish CL; Thomson LH; Rafii A; Elliott DA; Elefanty AG; Stanley EG
Stem Cell Reports; 2016 Sep; 7(3):518-526. PubMed ID: 27594589
[TBL] [Abstract][Full Text] [Related]
23. Defining essential genes for human pluripotent stem cells by CRISPR-Cas9 screening in haploid cells.
Yilmaz A; Peretz M; Aharony A; Sagi I; Benvenisty N
Nat Cell Biol; 2018 May; 20(5):610-619. PubMed ID: 29662178
[TBL] [Abstract][Full Text] [Related]
24. A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.
Zhu Z; Verma N; González F; Shi ZD; Huangfu D
Stem Cell Reports; 2015 Jun; 4(6):1103-11. PubMed ID: 26028531
[TBL] [Abstract][Full Text] [Related]
25. Doxycycline Masks the Genuine Effect of the Doxycycline-Inducible Transgene by Promoting Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells.
Cao D; Cheung HH; Chan WY
Stem Cells Dev; 2019 Jul; 28(13):833-845. PubMed ID: 31020917
[TBL] [Abstract][Full Text] [Related]
26. Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation.
Schoger E; Argyriou L; Zimmermann WH; Cyganek L; Zelarayán LC
Stem Cell Res; 2020 Oct; 48():101944. PubMed ID: 33038615
[TBL] [Abstract][Full Text] [Related]
27. Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells.
Petazzi P; Torres-Ruiz R; Fidanza A; Roca-Ho H; Gutierrez-Agüera F; Castaño J; Rodriguez-Perales S; Díaz de la Guardia R; López-Millán B; Bigas A; Forrester LM; Bueno C; Menéndez P
Mol Ther Nucleic Acids; 2020 Jun; 20():196-204. PubMed ID: 32171171
[TBL] [Abstract][Full Text] [Related]
28. Inducible and reversible lentiviral and Recombination Mediated Cassette Exchange (RMCE) systems for controlling gene expression.
Bersten DC; Sullivan AE; Li D; Bhakti V; Bent SJ; Whitelaw ML
PLoS One; 2015; 10(3):e0116373. PubMed ID: 25768837
[TBL] [Abstract][Full Text] [Related]
29. Cellular reprogramming with multigene activation by the delivery of CRISPR/dCas9 ribonucleoproteins via magnetic peptide-imprinted chitosan nanoparticles.
Lee MH; Lin CC; Thomas JL; Li JA; Lin HY
Mater Today Bio; 2021 Jan; 9():100091. PubMed ID: 33521619
[TBL] [Abstract][Full Text] [Related]
30. Generation of three isogenic gene-edited Huntington's disease human embryonic stem cell lines with DOX-inducible NGN2 expression cassette in the AAVS1 safe locus.
Villegas LD; Chandrasekaran A; Andersen SAF; Nørremølle A; Schmid B; Pouladi MA; Freude K
Stem Cell Res; 2024 Jun; 77():103408. PubMed ID: 38569398
[TBL] [Abstract][Full Text] [Related]
31. Gene targeting in human pluripotent stem cells with adeno-associated virus vectors.
Mitsui K; Suzuki K; Aizawa E; Kawase E; Suemori H; Nakatsuji N; Mitani K
Biochem Biophys Res Commun; 2009 Oct; 388(4):711-7. PubMed ID: 19695233
[TBL] [Abstract][Full Text] [Related]
32. Loss of the Otx2-Binding Site in the Nanog Promoter Affects the Integrity of Embryonic Stem Cell Subtypes and Specification of Inner Cell Mass-Derived Epiblast.
Acampora D; Omodei D; Petrosino G; Garofalo A; Savarese M; Nigro V; Di Giovannantonio LG; Mercadante V; Simeone A
Cell Rep; 2016 Jun; 15(12):2651-64. PubMed ID: 27292645
[TBL] [Abstract][Full Text] [Related]
33. Nanog RNA-binding proteins YBX1 and ILF3 affect pluripotency of embryonic stem cells.
Guo C; Xue Y; Yang G; Yin S; Shi W; Cheng Y; Yan X; Fan S; Zhang H; Zeng F
Cell Biol Int; 2016 Aug; 40(8):847-60. PubMed ID: 26289635
[TBL] [Abstract][Full Text] [Related]
34. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3.
Torres J; Watt FM
Nat Cell Biol; 2008 Feb; 10(2):194-201. PubMed ID: 18223644
[TBL] [Abstract][Full Text] [Related]
35. Cell-permeant recombinant Nanog protein promotes pluripotency by inhibiting endodermal specification.
Peitz M; Münst B; Thummer RP; Helfen M; Edenhofer F
Stem Cell Res; 2014 May; 12(3):680-9. PubMed ID: 24681518
[TBL] [Abstract][Full Text] [Related]
36. CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs.
Mandegar MA; Huebsch N; Frolov EB; Shin E; Truong A; Olvera MP; Chan AH; Miyaoka Y; Holmes K; Spencer CI; Judge LM; Gordon DE; Eskildsen TV; Villalta JE; Horlbeck MA; Gilbert LA; Krogan NJ; Sheikh SP; Weissman JS; Qi LS; So PL; Conklin BR
Cell Stem Cell; 2016 Apr; 18(4):541-53. PubMed ID: 26971820
[TBL] [Abstract][Full Text] [Related]
37. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.
Chan KK; Zhang J; Chia NY; Chan YS; Sim HS; Tan KS; Oh SK; Ng HH; Choo AB
Stem Cells; 2009 Sep; 27(9):2114-25. PubMed ID: 19522013
[TBL] [Abstract][Full Text] [Related]
38. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.
González F; Zhu Z; Shi ZD; Lelli K; Verma N; Li QV; Huangfu D
Cell Stem Cell; 2014 Aug; 15(2):215-226. PubMed ID: 24931489
[TBL] [Abstract][Full Text] [Related]
39. Nanog, Oct4 and Tet1 interplay in establishing pluripotency.
Olariu V; Lövkvist C; Sneppen K
Sci Rep; 2016 May; 6():25438. PubMed ID: 27146218
[TBL] [Abstract][Full Text] [Related]
40. iKA-CRISPR hESCs for inducible and multiplex orthogonal gene knockout and activation.
Ma S; Lv J; Sun J; Tang P; Li H; Zhou H; Zhang Z; Lin Y; Rong Z
FEBS Lett; 2018 Jul; 592(13):2238-2247. PubMed ID: 29869798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
